262 related articles for article (PubMed ID: 36286483)
21. An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators.
Cox MA; Leahy J; Hardwick JM
J Virol; 1990 Jan; 64(1):313-21. PubMed ID: 2152819
[TBL] [Abstract][Full Text] [Related]
22. Uracil DNA glycosylase BKRF3 contributes to Epstein-Barr virus DNA replication through physical interactions with proteins in viral DNA replication complex.
Su MT; Liu IH; Wu CW; Chang SM; Tsai CH; Yang PW; Chuang YC; Lee CP; Chen MR
J Virol; 2014 Aug; 88(16):8883-99. PubMed ID: 24872582
[TBL] [Abstract][Full Text] [Related]
23. Role of the TSG101 gene in Epstein-Barr virus late gene transcription.
Chua HH; Lee HH; Chang SS; Lu CC; Yeh TH; Hsu TY; Cheng TH; Cheng JT; Chen MR; Tsai CH
J Virol; 2007 Mar; 81(5):2459-71. PubMed ID: 17182691
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus (EBV) Rta-mediated EBV and Kaposi's sarcoma-associated herpesvirus lytic reactivations in 293 cells.
Chen YJ; Tsai WH; Chen YL; Ko YC; Chou SP; Chen JY; Lin SF
PLoS One; 2011 Mar; 6(3):e17809. PubMed ID: 21423768
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.
Almohammed R; Osborn K; Ramasubramanyan S; Perez-Fernandez IBN; Godfrey A; Mancini EJ; Sinclair AJ
J Gen Virol; 2018 Jun; 99(6):805-817. PubMed ID: 29580369
[TBL] [Abstract][Full Text] [Related]
26. Lytic cycle switches of oncogenic human gammaherpesviruses.
Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L
Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942
[TBL] [Abstract][Full Text] [Related]
27. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
Jiang Y; Xu D; Zhao Y; Zhang L
PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone.
Tung CP; Chang FR; Wu YC; Chuang DW; Hunyadi A; Liu ST
J Gen Virol; 2011 Aug; 92(Pt 8):1760-1768. PubMed ID: 21490247
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Epstein-Barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane.
Wu CC; Chuang HY; Lin CY; Chen YJ; Tsai WH; Fang CY; Huang SY; Chuang FY; Lin SF; Chang Y; Chen JY
Mol Carcinog; 2013 Dec; 52(12):946-58. PubMed ID: 22641235
[TBL] [Abstract][Full Text] [Related]
30. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
[TBL] [Abstract][Full Text] [Related]
31. The Epstein-Barr Virus BMRF1 Protein Activates Transcription and Inhibits the DNA Damage Response by Binding NuRD.
Salamun SG; Sitz J; De La Cruz-Herrera CF; Yockteng-Melgar J; Marcon E; Greenblatt J; Fradet-Turcotte A; Frappier L
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462557
[TBL] [Abstract][Full Text] [Related]
32. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
[TBL] [Abstract][Full Text] [Related]
33. Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.
Zhou Y; Heesom K; Osborn K; AlMohammed R; Sweet SM; Sinclair AJ
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694936
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of the Epstein-Barr virus lytic cycle by moronic acid.
Chang FR; Hsieh YC; Chang YF; Lee KH; Wu YC; Chang LK
Antiviral Res; 2010 Mar; 85(3):490-5. PubMed ID: 19969023
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization.
Heilmann AM; Calderwood MA; Johannsen E
J Virol; 2010 Oct; 84(19):9920-31. PubMed ID: 20631124
[TBL] [Abstract][Full Text] [Related]
36. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
37. Luteolin inhibits Epstein-Barr virus lytic reactivation by repressing the promoter activities of immediate-early genes.
Wu CC; Fang CY; Hsu HY; Chen YJ; Chou SP; Huang SY; Cheng YJ; Lin SF; Chang Y; Tsai CH; Chen JY
Antiviral Res; 2016 Aug; 132():99-110. PubMed ID: 27185626
[TBL] [Abstract][Full Text] [Related]
38. Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.
Siddiqi UZ; Vaidya AS; Li X; Marcon E; Tsao SW; Greenblatt J; Frappier L
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341047
[TBL] [Abstract][Full Text] [Related]
39. Multivalent sequence recognition by Epstein-Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain.
Wang P; Day L; Lieberman PM
J Virol; 2006 Nov; 80(22):10942-9. PubMed ID: 16971443
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cellular and viral protein expression by the Epstein-Barr virus transcriptional regulator Zta: implications for therapy of EBV associated tumors.
Chen C; Li D; Guo N
Cancer Biol Ther; 2009 Jun; 8(11):987-95. PubMed ID: 19448399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]